Patents by Inventor Lyudmila Burdelya

Lyudmila Burdelya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of toll-like receptor agonist for treating cancer
    Patent number: 11628201
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Grant
    Filed: July 21, 2020
    Date of Patent: April 18, 2023
    Assignee: Cleveland BioLabs, Inc.
    Inventors: Anatoli Gleiberman, Lyudmila Burdelya, Andrei Gudkov
  • USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER
    Publication number: 20210169972
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Application
    Filed: July 21, 2020
    Publication date: June 10, 2021
    Inventors: Anatoli GLEIBERMAN, Lyudmila BURDELYA, Andrei GUDKOV
  • Use of toll-like receptor agonist for treating cancer
    Patent number: 10780152
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Grant
    Filed: February 19, 2019
    Date of Patent: September 22, 2020
    Assignee: Cleveland BioLabs, Inc.
    Inventors: Anatoli Gleiberman, Lyudmila Burdelya, Andrei Gudkov
  • USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER
    Publication number: 20190275128
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Application
    Filed: February 19, 2019
    Publication date: September 12, 2019
    Inventors: Anatoli GLEIBERMAN, Lyudmila BURDELYA, Andrei GUDKOV
  • Use of toll-like receptor agonist for treating cancer
    Patent number: 10265390
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Grant
    Filed: June 21, 2018
    Date of Patent: April 23, 2019
    Assignee: CLEVELAND BIOLABS, INC.
    Inventors: Anatoli Gleiberman, Lyudmila Burdelya, Andrei Gudkov
  • USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER
    Publication number: 20180344823
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Application
    Filed: June 21, 2018
    Publication date: December 6, 2018
    Inventors: Anatoli Gleiberman, Lyudmila Burdelya, Andrei Gudkov
  • Use of toll-like receptor agonist for treating cancer
    Patent number: 10034926
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Grant
    Filed: June 23, 2017
    Date of Patent: July 31, 2018
    Assignee: Cleveland BioLabs, Inc.
    Inventors: Anatoli Gleiberman, Lyudmila Burdelya, Andrei Gudkov
  • USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER
    Publication number: 20180028628
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Application
    Filed: June 23, 2017
    Publication date: February 1, 2018
    Inventors: Anatoli Gleiberman, Lyudmila Burdelya, Andrei Gudkov
  • USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER
    Publication number: 20170065692
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Application
    Filed: August 19, 2016
    Publication date: March 9, 2017
    Inventors: Anatoli Gleiberman, Lyudmila Burdelya, Andrei Gudkov
  • USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER
    Publication number: 20160206690
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Application
    Filed: November 23, 2015
    Publication date: July 21, 2016
    Inventors: Anatoli Gleiberman, Lyudmila Burdelya, Andrei Gudkov
  • Use of Toll-Like Receptor agonist for treating cancer
    Patent number: 9376473
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Grant
    Filed: January 10, 2012
    Date of Patent: June 28, 2016
    Assignee: Cleveland BioLabs, Inc.
    Inventors: Anatoli Gleiberman, Lyudmila Burdelya, Andrei Gudkov
  • COMPOSITIONS AND METHODS COMPRISING TOLL LIKE RECEPTOR (TLR) STIMULATING AGENTS FOR PROPHYLAXIS AND THERAPY FOR DAMAGE TO DERMAL EPITHELIUM
    Publication number: 20150328284
    Abstract: Provided are compositions and methods for prophylaxis and/or therapy of dermal damage. The compositions and methods involve Toll like receptor (TLR) agonists that can inhibit the formation or accelerate healing of dermal damage, and/or inhibit inflammation at near the location of the dermal damage. The TLR agonists can be TLR2 and/or TLR5 agonists. The compositions and methods are suitable for prophylaxis and/or therapy of dermal damage caused by radiation, or non-radiation thermal injury such as burns caused by contact with heated surfaces or heated objects, light, and for disruptions in integument resulting in cuts, such as incisions, or punctures. The compositions can be used topically, subcutaneously or systemically. Articles of manufacture coated or impregnated with TLR agonist(s) are also provided.
    Type: Application
    Filed: April 2, 2013
    Publication date: November 19, 2015
    Inventors: Andrei GUDKOV, Lyudmila BURDELYA
  • USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER
    Publication number: 20140248260
    Abstract: The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
    Type: Application
    Filed: January 10, 2012
    Publication date: September 4, 2014
    Applicant: CLEVELAND BIOLABS, INC.
    Inventors: Anatoli Gleiberman, Lyudmila Burdelya, Andrei Gudkov
  • Method of Reducing The Effects of Chemotherapy Using Flagellin Related Polypeptides
    Publication number: 20130324462
    Abstract: The use of flagellin and flagellin related polypeptides for reducing cancer treatment side effects in mammals is described.
    Type: Application
    Filed: March 26, 2013
    Publication date: December 5, 2013
    Inventors: Andrei V. Gudkov, Vadim Krivokrysenko, Lyudmila Burdelya
  • Method for reducing the effects of chemotherapy using flagellin related polypeptides
    Patent number: 8580321
    Abstract: The use of flagellin and flagellin related polypeptides for reducing cancer treatment side effects in mammals is described.
    Type: Grant
    Filed: February 11, 2009
    Date of Patent: November 12, 2013
    Assignee: The Cleveland Clinic Foundation
    Inventors: Andrei V. Gudkov, Vadim Krivokrysenko, Lyudmila Burdelya
  • Method for Reducing The Effects of Chemotherapy Using Flagellin Related Polypeptides
    Publication number: 20090246303
    Abstract: The use of flagellin and flagellin related polypeptides for reducing cancer treatment side effects in mammals is described.
    Type: Application
    Filed: February 11, 2009
    Publication date: October 1, 2009
    Inventors: Andrei V. Gudkov, Vadim Krivokrysenko, Lyudmila Burdelya